|
SBIR Phase II, Topic 255: Development of Novel Anticancer Agent to Potentiate Se
|
N44CO140040-000
|
$1,478,552
|
$739,276
|
SERRERO, GINETTE
|
A&G PHARMACEUTICAL, INC
|
|
Developing Novel Therapies for Treating Breast-Cancer-Related Lymphedema
|
1R41CA183335-01
|
$225,000
|
$225,000
|
HSU, SHEAU-YU
|
ADEPTHERA, LLC
|
|
SBIR Phase I Topic 328 Project Titled: ""Tumor-Micorenvironment-on Chip of Breas
|
N43CO140021-000
|
$208,489
|
$208,489
|
PARK, HAESUN
|
AKINA, INC.
|
|
Diffusion Weighted Breast MR Imaging for Screening Women with Dense Breasts
|
2R44CA186313-02
|
$798,404
|
$798,404
|
PENN, ALAN
|
ALAN PENN AND ASSOCIATES, INC.
|
|
MOTILITY AND INVASION
|
2P01CA100324-11A1
|
$2,028,990
|
$2,028,990
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Signal Transduction & Actin During Amoeboid Chemotaxis
|
5R01CA150344-26
|
$343,213
|
$343,213
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Tumor microenvironments determing migration, dissemination and dormancy
|
5U54CA163131-04
|
$862,508
|
$569,255
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Systems microscopy analysis of tumor cell motility in microenvironment context
|
5K99CA172360-02
|
$138,712
|
$138,712
|
GLIGORIJEVIC, BOJANA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$19,500
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$38,610
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$932,164
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Rac1 regulates protrusion and invasion of breast cancers in 3D
|
1R21CA181838-01A1
|
$181,613
|
$181,613
|
HODGSON, LOUIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Novel approach to study intravasation in primary human breast cancer cells(PQ24)
|
5R01CA170507-03
|
$341,989
|
$341,989
|
OKTAY, MAJA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The Metastatic Cascade: Macrophages Lead the Way
|
5R01CA172451-02
|
$426,219
|
$140,652
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
microRNA expression profiling of benign breast tissue and breast cancer risk
|
5R01CA142942-05
|
$569,377
|
$569,377
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
|
5R01CA164468-04
|
$734,934
|
$514,454
|
VERKHUSHA, VLADISLAV
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The B7x pathway in the tumor microenvironment
|
1R01CA175495-01A1
|
$346,525
|
$86,631
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The B7x pathway in the tumor microenvironment
|
3R01CA175495-01A1S1
|
$59,075
|
$14,769
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$12,524
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
A Potent Small Molecule Chemokine Antagonist Blocks Tumor Cell Dissemination In V
|
1R43CA183362-01A1
|
$224,748
|
$112,374
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
2014 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA186413-01
|
$2,500
|
$825
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
Decoy Peptides: Development of a Novel Therapeutic for Metastatic Cancer
|
3R41CA173937-01A1S1
|
$119,600
|
$119,600
|
CAMENISCH, TODD
|
ARIZONA CANCER THERAPEUTICS, LLC
|
|
Molecular Recognition by Bleomycin
|
5R01CA140471-05
|
$297,737
|
$297,737
|
HECHT, SIDNEY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Biomarker Detection Using NAPPA Tumor Antigen Arrays
|
3U01CA117374-10S1
|
$192,353
|
$192,353
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Biomarker Detection Using NAPPA Tumor Antigen Arrays
|
5U01CA117374-10
|
$710,359
|
$710,359
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Detection and validation of miRNA targets in breast cancer
|
1R21CA179144-01A1
|
$194,217
|
$194,217
|
MANGONE, MARCO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
$24,308
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Risk Prediction for ER Negative Breast Cancer Recurrence
|
5R01CA172511-02
|
$603,134
|
$603,134
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
|
2R01CA072038-16A1
|
$319,275
|
$319,275
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Elucidating the functions of Bud31, an essential gene in Myc-driven breast cance
|
5F30CA180447-02
|
$44,838
|
$44,838
|
HSU, TIFFANY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Molecularly guided multimodal theranostics for breast cancer
|
5R01CA151962-05
|
$317,684
|
$317,684
|
JOSHI, AMIT
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mitochondria specific metabolomic signature in triple negative breast cancer meta
|
5R21CA173150-02
|
$165,089
|
$165,089
|
KAIPPARETTU, BENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mitochondria-nuclear crosstalk in triple negative breast cancer racial disparity
|
5R21CA179720-02
|
$165,089
|
$165,089
|
KAIPPARETTU, BENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Oncogene susceptibility: physiological state & breast cell differentiation
|
5R01CA124820-05
|
$299,692
|
$299,692
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Characterization and targeting BRIT1 deficiency in breast cancer
|
5R01CA155151-04
|
$314,996
|
$314,996
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Heparanase Mechanisms in Brain-metastatic Breast Cancer
|
5R01CA160335-04
|
$288,430
|
$288,430
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
1P50CA186784-01
|
$2,162,000
|
$2,162,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
$20,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
$13,185
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
$40,446
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$741,620
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Hormonal Regulation of Breast Cancer
|
5R01CA016303-39
|
$776,951
|
$776,951
|
ROSEN, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
|
5R01CA148761-05
|
$471,844
|
$471,844
|
ROSEN, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
|
High Kynurenine in Agressive Triple Negative African American Breast Cancer
|
1R21CA185516-01
|
$204,233
|
$204,233
|
SREEKUMAR, ARUN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Delineating racially distinct metabolic pathways in triple negative breast cancer
|
1U01CA179674-01A1
|
$348,403
|
$348,403
|
SREEKUMAR, ARUN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integrative Consig: NLK as Attractive Drug Target for Intractable Breast Cancer
|
1R01CA181368-01A1
|
$324,738
|
$324,738
|
WANG, XIAOSONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
CHARACTERIZATION OF RECURRENT ADJACENT GENE TRANSLOCATIONS IN BREAST CANCER
|
1R01CA183976-01
|
$336,212
|
$336,212
|
WANG, XIAOSONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovering genetic networks of triple-negative breast cancer
|
5R01CA178039-02
|
$314,996
|
$314,996
|
WESTBROOK, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of SRC-1 in Breast Cancer
|
5R01CA112403-08
|
$261,640
|
$261,640
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc
|
1R01CA183878-01
|
$324,738
|
$324,738
|
ZHANG, XIANG
|
BAYLOR COLLEGE OF MEDICINE
|
Total relevant funding to Breast for this search: $528,546,755
|